Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
dante.rotili@uniroma1.it
Dante Rotili
Professore Associato
Struttura:
DIPARTIMENTO DI CHIMICA E TECNOLOGIE DEL FARMACO
E-mail:
dante.rotili@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity
JOURNAL OF MEDICINAL CHEMISTRY
2024
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer
CANCER CELL INTERNATIONAL
2024
Pyrimidine thioethers: A novel class of antidepressant agents, endowed with anxiolytic, performance enhancing and nootropic activity
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
2023
Systematic Design of Adenosine Analogs as Inhibitors of a Clostridioides difficile-Specific DNA Adenine Methyltransferase Required for Normal Sporulation and Persistence
JOURNAL OF MEDICINAL CHEMISTRY
2023
METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
JOURNAL OF MEDICINAL CHEMISTRY
2023
Simultaneous administration of EZH2 and BET inhibitors inhibits proliferation and clonogenic ability of metastatic prostate cancer cells
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
2023
GreenMedChem- the challenge in the next decade toward eco-friendly compounds and processes in drug design
GREEN CHEMISTRY
2023
Role of SIRT3 in Microgravity Response: A New Player in Muscle Tissue Recovery
CELLS
2023
Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
2023
Emerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
CELLS
2023
Native mass spectrometry-directed drug discovery: Recent advances in investigating protein function and modulation
DRUG DISCOVERY TODAY
2023
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8
JOURNAL OF MEDICINAL CHEMISTRY
2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer Cells
JOURNAL OF MEDICINAL CHEMISTRY
2023
Molecular insights into RmcA-mediated c-di-GMP consumption: Linking redox potential to biofilm morphogenesis in Pseudomonas aeruginosa.
MICROBIOLOGICAL RESEARCH
2023
The role of structural biology in the design of sirtuin activators
CURRENT OPINION IN STRUCTURAL BIOLOGY
2023
State of the art of carbonic anhydrase activators
FUTURE MEDICINAL CHEMISTRY
2023
Hydroxamate-based compounds are potent inhibitors of Toxoplasma gondii HDAC biological activity
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
2023
SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells
INFLAMMATION
2023
Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a Clostridioides difficile-Specific DNA Adenine Methyltransferase
ACS CHEMICAL BIOLOGY
2023
BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress
ANTIOXIDANTS
2023
1
2
3
4
5
6
seguente ›
ultima »
Progetti di Ricerca
Modulators of epigenetic targets for the treatment of parasitic diseases.
Development of novel LSD1 inhibitors as potential new generation anticancer agents.
Development of glucose-based pure beta minus radiotracers potentially suitable for tumor radioguided surgery.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma